Sabin and wild polioviruses from apparently healthy primary school children in northeastern Nigeria

Journal of Medical Virology

Volumn 84, Issue 2, 2012, Pages 358-364

  Baba, M M ^a   Oderinde, B S ^a   Patrick, P Z ^a   Jarmai, M M ^a  

^a UNIVERSITY OF MAIDUGURI   (Nigeria)

Author keywords

Healthy children; Immunization; Nigeria; Polio vaccine; Polioviruses

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENVIRONMENT; FECES ANALYSIS; FEMALE; GENE SEQUENCE; HERD IMMUNITY; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NIGERIA; POLIOMYELITIS; POLIOMYELITIS VIRUS; POPULATION; PRESCHOOL CHILD; SABIN POLIOVIRUS; SCHOOL CHILD; SEROTYPE; TISSUE CULTURE; VACCINATION; VIRUS EXCRETION; VIRUS ISOLATION; VIRUS TRANSMISSION; WILD POLIOVIRUS;

ADOLESCENT; CARRIER STATE; CHILD; CHILD, PRESCHOOL; FECES; FEMALE; GENOTYPE; HUMANS; IMMUNITY, HERD; IMMUNIZATION PROGRAMS; MALE; NIGERIA; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; SEQUENCE ANALYSIS, DNA; VACCINATION; VIRUS SHEDDING;

EID: 83655197232     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23184     Document Type: Article

References (30)

1. Adu FD, Odemuyiwa SO, Tomori O. 1996. Circulation of poliviruses among risk groups in Ibadan, Nigeria. Trans R Soc Trop Med Hyg 90:126-127.
2. Centers for Disease Control and Prevention. 2001. Apparent global interruption of wild poliovirus type 2 transmission. MMWR Morb Mortal Wkly Rep 50:222.
3. Centers for Disease Control and Prevention. 2008. Epi Info, version 3.5.1 software.
4. Centers for Disease Control and Prevention. 2009. Update on vaccine-derived polioviruses worldwide. 2008-2009. Morb Mortal Wkly Rep 58:1002-1006.
5. Centers for Disease Control and Prevention. 2010. Progress toward Poliomyelitis Eradication in Nigeria, January 2009-June 2010. Morb Mortal Wkly Rep 59:802-807.
6. Debre R, Thieffery S. 1955. Symptomatology and diagnosis of poliomyelitis. In: Debre R, Thieffery S, editors. Poliomyelitis. Geneva: World Health Organization, pp 109-136. WHO Monograph Series, No.26.
7. Donbraye E, Adewumi MO, Odaibo GN, Bakarey AS, Opaleye OO, Olaleye OO. 2011. Evaluation of immunity against poliovirus serotypes among children in riverine areas of Delta State, Nigeria. Afr J Clin Environ Microbiol 12:72-75.
8. Global Polio Eradication Initiative. Available from: [accessed on April 17, 2010].
9. Grassly NC, Jafari H, Bahl S, Durrani S, Wemger J, Sutter RW, Aylward RB. 2010. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. J Infect Dis 201:1535-1543.
10. Guerrera M. 2007. Finish polio: Evolutionary medicine principles and the eradication of polio final project for BIO 540-Evolutionary medicine.
11. Hughes SA, Thaker HM, Racaniello VR. 2003. Transgenic mouse model for Echovirus myocarditis and paralysis. Proc Natl Acad Sci USA 26:15906-15911.
12. Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Mwanza M, Corander J, Garnier S, Chauvin C, Abanida E, Pate MA, Adu F, Baba M, Grassly NC. 2010. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med 362:2360-2369.
13. Kilpatrick DR, Nottay B, Yang CF, Yang SJ, Mulders MN, Holloway BP, Pallansch MA, Kew OM. 1996. Group-specific identification of polioviruses by PCR using primers containing mixed-based or deoxyinosine residues at positions of codon degeneracy. J Clin Microbiol 34:2990-2996.
14. Kilpatrick DR, Nottay B, Yang C-F, Yang SJ, Mulders MN, Holloway BP, Pallansch MA, Kew OM. 1998. Seotype-specific identification of polioviruses by PCR using primers containing mixed-based or deoxyinosine residues at positions of codon degeneracy. J Clin Microbiol 36:352-357.
15. Kilpatrick DR, Iber JC, Chen Q, Ching K, Yang SJ, De L, Mandlebaum MD, Emery B, Campagnoli R, Burns CC, Kew O. 2011. Poliovirus serotype-specific VP1 sequencing primers. J Virol Methods 174:128-130.
16. Kimura M. 1980. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111-120.
17. Nathanson N. 2011. Eradication of poliovirus: Fighting fire with fire. J Infect Dis 203:889-890.
18. Nathanson N, Martin JR. 1979. The epidemiology of poliomyelitis: Enigmas surrounding its appearance, epidemicity and disappearance. Am J Epidemiol 110:672-692.
19. Needleman SB, Wunsch CD. 1970. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol 48:443-453.
20. Oderinde BS, Olabode AO, Harry TO, Baba MM, Bukbuk DN, Ogunmola OO. 2007. Non-polio-enteroviruses implicated in acute flaccid paralysis in northern Nigeria. Res J Med Med Sci 2:25-28.
21. Report, of the 20th meeting of the Expert Review committee (ERC) on polio eradication and routine immunization in Nigeria held in Abuja on 4th-5th October 2010.
22. Saitou N, Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425.
23. Shibuya K, Murray CJL. 2004. Poliomyelitis.
24. Sutter RW, Kew OM, Cocchi SL. 2004. Poliovirus vaccine-live. In: Plotkin SA, Orenstein WA, editors. Vaccines, 4th edition. Philadelphia: WB Saunders Company, pp 651-705.
25. van der Avoort HG, Hull BP, Hovi T, Pallansch MA, Kew OM, Crainic R, Wood DJ, Mulders MN, van Loon AM. 1995. A comparative study of five methods of intratypic differentiation of polioviruses. J Clin Microbiol 33:2562-2566.
26. Wassilak S, Pate MA, Wannemuuehler K, Jenks J, Burns C, Chenoweth P, Abanida EA, Adu F, Baba MM, Gasasira A, Iber J, Mkanda P, Williams J, Shaw J, Pallansch M, Kew O. 2011. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: Emergence and widespread circulation in an underimmunized population. J Infect Dis 203:898-909.
27. World Health Organization. 2003. Guidelines for environmental surveillance of poliovirus circulation. Vaccines and biological.
28. World Health Organization Polio Laboratory Manual. 2004. Isolation and identification of polioviruses, 4th edition. Geneva: WHO.
29. World Health Organization. 2009. Conclusions and Recommendations of the Advisory Committee on Poliomyelitis Eradication, November 2008. Wkly Epidemiol Rec 84:17-28.
30. Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, Campagnoli R, van der Avoort H, Shimizu H, Yoneyama T, Miyamura T, Pallansch M, Kew O. 2003. Circulation of endemic type 2 vaccine derived poliovirus in Egypt, 1983-1993. J Virol 77:8366-8377.